Deferred Tax Assets, Valuation Allowance of Bio Essence Corp from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bio Essence Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Bio Essence Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $1,326,082, a 103% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Bio Essence Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,326,082 +$673,440 +103% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $699,836 +$75,871 +12% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $716,812 +$153,202 +27% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $659,235 +$22,843 +3.6% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $652,642 -$1,017,532 -61% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $623,965 -$976,056 -61% 30 Jun 2024 10-Q/A 27 Nov 2024 2024 Q2
Q1 2024 $563,610 -$970,699 -63% 31 Mar 2024 10-Q/A 27 Nov 2024 2024 Q1
Q4 2023 $636,392 -$848,341 -57% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $1,670,174 +$244,699 +17% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,600,021 +$296,651 +23% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $1,534,309 +$275,650 +22% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $1,484,733 +$288,273 +24% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q3 2022 $1,425,475 -$226,084 -14% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,303,370 -$306,919 -19% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $1,258,659 -$307,327 -20% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $1,196,460 -$310,554 -21% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,651,559 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $1,610,289 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,565,986 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $1,507,014 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.